510(k) K924113

ABUSCREEN ONLINE FOR COCAINE METABOLITE by Roche Diagnostic Systems, Inc. — Product Code DLN

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 28, 1992
Date Received
August 13, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Hemagglutination, Cocaine Metabolites (Benzoylecgnonine)
Device Class
Class II
Regulation Number
862.3250
Review Panel
TX
Submission Type